Drugs incorporated into the Brazilian Unified Health System: document analysis of methodological decisions in budget impact analyses between 2012 and 2024. [PDF]
Epidemiol Serv SaudeCurado DDSP, Silva END.
europepmc +1 more source
Healthcare judicialization: an analysis of indicators and official data on medications. [PDF]
Rev Bras EnfermBernardinis N +3 more
europepmc +1 more source
Health surveillance at mass gatherings: experience report from the Strategic Health Surveillance Information Center in the city of Rio de Janeiro, 2024. [PDF]
Epidemiol Serv SaudePimenta IT +7 more
europepmc +1 more source
[Educational actions in Healthcare Planning: professionals' perceptions in two Health Regions of Brazil]. [PDF]
Cad Saude PublicaGuerra S +8 more
europepmc +1 more source
Miltefosine implementation for treatment of cutaneous leishmaniasis: access indicators in the state of Minas Gerais, 2021-2024. [PDF]
Epidemiol Serv SaudeSilva SN, Saliba MF, Ribeiro LR, Cota G.
europepmc +1 more source
The case of eculizumab: litigation and purchases by the Brazilian Ministry of Health. [PDF]
Rev Saude Publica, 2020 Caetano R +4 more
europepmc +1 more source
[State and capital accumulation in Brazilian health from the perspective of the Marxist Dependency Theory]. [PDF]
Cad Saude PublicaRodrigues PHA +4 more
europepmc +1 more source
Health financing in Brazil and the goals of the 2030 Agenda: high risk of failure. [PDF]
Rev Saude Publica, 2020 Vieira FS.
europepmc +1 more source
Root cause analysis of safety incidents in antineoplastic use in children. [PDF]
Rev Bras EnfermBarreto EDG +5 more
europepmc +1 more source
[Access to medicines for the treatment of systemic arterial hypertension and type 2 diabetes mellitus in the Brazilian population: data from the 2019 Brazilian National Health Survey]. [PDF]
Cad Saude PublicaLeal AAF, Galvão MHR, Roncalli ÂG.
europepmc +1 more source